Insider · CIK 0001916048

Warren Eric

Reports to the SEC for 2 companies · RADNOR, PA

sec.gov

Transactions

Companies

Filings

CIK

0001916048

Forms 4 and 5

Insider transactions

47 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-21	MLYSMineralys Therapeutics, Inc.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+7,438 sh	$13.24	+$98.5K	45,838
2026-09-21	MLYSMineralys Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−7,438 sh	$28.12	−$209K	38,400
2026-09-21	MLYSMineralys Therapeutics, Inc. · Stock OptionM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−7,438 sh	—	—	230,563
2026-08-21	MLYSMineralys Therapeutics, Inc.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+7,437 sh	$13.24	+$98.5K	45,837
2026-08-21	MLYSMineralys Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−7,437 sh	$25.98	−$193K	38,400
2026-08-21	MLYSMineralys Therapeutics, Inc. · Stock OptionM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−7,437 sh	—	—	238,001
2026-07-21	MLYSMineralys Therapeutics, Inc.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+7,438 sh	$13.24	+$98.5K	45,838
2026-07-21	MLYSMineralys Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−7,438 sh	$26.87	−$200K	38,400
2026-07-21	MLYSMineralys Therapeutics, Inc. · Stock OptionM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−7,438 sh	—	—	245,438
2026-06-26	MLYSMineralys Therapeutics, Inc.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+104K sh	$13.24	+$1.38M	142,524
2026-06-26	MLYSMineralys Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−104K sh	$25.90	−$2.7M	38,400
2026-06-26	MLYSMineralys Therapeutics, Inc. · Stock OptionM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−104K sh	—	—	252,876
2025-04-17	ESPREsperion Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−108 sh	$0.98	−$105.624	370,218
2025-03-18	ESPREsperion Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−2,433 sh	$1.49	−$3,617.871	370,326
2025-03-14	ESPREsperion Therapeutics, Inc.A Award	Chief Commercial Officer	AAward	+213K sh	—	—	372,759
2025-03-14	ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Commercial Officer	AAward	+191K sh	—	—	191,000
2025-02-19	ESPREsperion Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−239 sh	$1.87	−$446.452	159,759
2025-01-17	ESPREsperion Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−123 sh	$2.26	−$277.98	159,998
2024-12-17	ESPREsperion Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−2,234 sh	$2.43	−$5,426.386	160,121
2024-11-19	ESPREsperion Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−197 sh	$2.17	−$426.505	162,355
2024-10-17	ESPREsperion Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−107 sh	$2.12	−$226.733	162,552
2024-09-17	ESPREsperion Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−2,608 sh	$1.78	−$4,650.064	162,659
2024-08-19	ESPREsperion Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−211 sh	$1.95	−$410.606	165,267
2024-07-17	ESPREsperion Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−108 sh	$2.59	−$279.396	165,478
2024-06-18	ESPREsperion Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−2,540 sh	$2.86	−$7,254.24	165,586
2024-05-17	ESPREsperion Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−192 sh	$2.48	−$476.736	168,126
2024-03-14	ESPREsperion Therapeutics, Inc.A Award	Chief Commercial Officer	AAward	+100K sh	—	—	168,318
2024-03-14	ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Commercial Officer	AAward	+150K sh	—	—	150,000
2023-09-20	ESPREsperion Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−742 sh	$1.25	−$923.79	68,318
2023-08-18	ESPREsperion Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−243 sh	$1.41	−$343.602	69,060
2023-07-19	ESPREsperion Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−106 sh	$1.58	−$168.01	69,303
2023-06-21	ESPREsperion Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−603 sh	$1.48	−$894.249	69,409
2023-05-17	ESPREsperion Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−219 sh	$1.62	−$355.656	70,012
2023-04-19	ESPREsperion Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−115 sh	$1.28	−$146.97	70,231
2023-03-17	ESPREsperion Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−526 sh	$1.78	−$937.49	70,346
2023-03-14	ESPREsperion Therapeutics, Inc.A Award	Chief Commercial Officer	AAward	+22.3K sh	—	—	70,872
2023-03-14	ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Commercial Officer	AAward	+94.5K sh	—	—	94,500
2023-03-07	ESPREsperion Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−5,090 sh	$5.05	−$25.7K	48,572
2022-10-18	ESPREsperion Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−107 sh	$7.69	−$822.83	53,662
2022-09-19	ESPREsperion Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−255 sh	$6.92	−$1,764.855	53,769
2022-08-31	ESPREsperion Therapeutics, Inc.P Purchase	Chief Commercial Officer	PPurchase	+1,000 sh	$7.46	+$7,460	54,024
2022-08-17	ESPREsperion Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−199 sh	$6.82	−$1,356.185	53,024
2022-07-19	ESPREsperion Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−431 sh	$6.58	−$2,836.842	53,223
2022-06-17	ESPREsperion Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−256 sh	$4.90	−$1,254.4	53,654
2022-06-07	ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Commercial Officer	AAward	+52K sh	—	—	52,000
2022-05-17	ESPREsperion Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−196 sh	$5.98	−$1,172.276	53,910
2022-03-14	ESPREsperion Therapeutics, Inc.A Award	Chief Commercial Officer	AAward	+13K sh	—	—	54,106

Recent filings

Accepted (ET)
Sep 224
Warren Eric0001916048-26-000014
SEC(opens sec.gov)
Aug 254
Warren Eric0001916048-26-000012
SEC(opens sec.gov)
Jul 234
Warren Eric0001916048-26-000009
SEC(opens sec.gov)
Jun 304
Warren Eric0001933414-26-000095
SEC(opens sec.gov)
Apr 214
Warren Eric0001628280-25-018567
SEC(opens sec.gov)
Mar 194
Warren Eric0001628280-25-013811
SEC(opens sec.gov)
Mar 174
Warren Eric0001628280-25-013196
SEC(opens sec.gov)
Feb 204
Warren Eric0001628280-25-006802
SEC(opens sec.gov)
Jan 214
Warren Eric0001628280-25-002035
SEC(opens sec.gov)
Dec 184
Warren Eric0001628280-24-051870
SEC(opens sec.gov)
Nov 204
Warren Eric0001628280-24-048659
SEC(opens sec.gov)

Companies

Address

150 N. RADNOR CHESTER ROAD SUITE F200

RADNOR, PA, 19087